2010NCCN中文版:卵巢癌.pdf
2010NCCN中文版:卵巢癌.pdf
Copyright © National Comprehensive Cancer Network 2010. All rights reserved. “NCCN”, the NCCN logo, and “National Comprehensive Cancer Network” are
registered trademarks of the National Comprehensive Cancer Network.
The Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Ovarian Cancer Guideline 2010 is the Chinese adapted version of NCCN Clinical Practice
Guidelines in Oncology-Ovarian Cancer Guideline, V.2.2010 as permitted and endorsed by NCCN. It is the collaborative outcome of the National Comprehensive
Cancer Network and Chinese key opinion leaders of the field.
The original guideline and Chinese edition are both available at: http://www.nccn.org. To view the most recent and complete version of the guideline, go online to
www.nccn.org. These Guidelines and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the NCCN.
These Guidelines are a work in progress that will be refined as often as new significant data becomes available. The NCCN Guidelines are a statement of consensus
of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult any NCCN guideline is expected to use
independent medical judgment in the context of individual clinical circumstance to determine any patient's care or treatment. The National Comprehensive Cancer
Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
This publication should not be used for commercial purpose. It is provided for free to Chinese medical professions with the support of the unrestrictive educational
grant of GlaxoSmithKline (China) Investment Co., Ltd. which exerts no influence to the formation of the Chinese edition of NCCN Clinical Practice Guidelines in
Oncology-Ovarian Cancer Guideline 2010.
NCCN ® 肿瘤学临床实践指南(中国版)2010年 第一版
© National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.
The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive
Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org.
卵巢癌
NCCN卵巢癌专家组成员
妇科肿瘤
血液科/血液肿瘤科
肿瘤内科
放疗/放射肿瘤科
内科
包括姑息治疗和疼痛
处理的支持治疗
编委会成员
Ω
‡
†
§
Þ
£
*
* Robert J. Morgan, Jr., MD/Chair ‡
City of Hope Comprehensive Cancer Center
* Ronald D. Alvarez, MD Ω
University of Alabama at Birmingham
Comprehensive Cancer Center
* Deborah K. Armstrong, MD † Ω
The Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins
Barry Boston, MD † £
St. Jude Children’s Hospital/University of
Tennessee Cancer Institute
* Robert A. Burger, MD Ω
Fox Chase Cancer Center
* Lee-may Chen, MD Ω
UCSF Helen Diller Family Comprehensive
Cancer Center
* Larry Copeland, MD Ω
Arthur G. James Cancer Hospital & Richard J.
Solove Research Institute at The Ohio State
University
Marta Ann Crispens, MD Ω
Vanderbilt-Ingram Cancer Center
* David K. Gaffney, MD, PhD §
Huntsman Cancer Institute at the University
of Utah
* David Gershenson, MD Ω
The University of Texas
M. D. Anderson Cancer Center
Heidi Gray, MD
Fred Hutchinson Cancer Research
Center/Seattle Cancer Care Alliance
* Benjamin E. Greer, MD Ω
Fred Hutchinson Cancer Research
Center/Seattle Cancer Care Alliance
Perry W. Grigsby, MD, MS, MBA §
Siteman Cancer Center at Barnes-Jewish
Hospital and Washington University
School of Medicine
* Laura J. Havrilesky, MD Ω
Duke Comprehensive Cancer Center
Carolyn Johnston, MD Ω
University of Michigan Comprehensive
Cancer Center
* Johnathan M. Lancaster, MD, PhD Ω
H. Lee Moffitt Cancer Center & Research
Institute
* Shashikant Lele, MD Ω
Roswell Park Cancer Institute
* Maurie Markman, MD † Ω
The University of Texas M. D. Anderson
Cancer Center
* Ursula A. Matulonis, MD †
Dana-Farber/Brigham and Women’s
Cancer Center
* David M. O’Malley, MD Ω
Arthur G. James Cancer Hospital &
Richard J. Solove Research Institute at
The Ohio State University
* Richard T. Penson, MD, MRCP †
Massachusetts General Hospital Cancer
Center
* Steven W. Remmenga, MD Ω
UNMC Eppley Cancer Center at The
Nebraska Medical Center
Paul Sabbatini, MD † Þ
Memorial Sloan-Kettering Cancer Center
* Russell J. Schilder, MD† ‡
Fox Chase Cancer Center
* Julian Schink, MD Ω
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University
Nelson Teng, MD, PhD Ω
Stanford Comprehensive Cancer Center
NCCN ®卵巢癌 肿瘤学临床实践指南(中国版)2010年 第一版
© National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.
The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive
Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org.
NCCN特别鸣谢
NCCN指南中国版专家组
召集人:
孙 燕
中国医学科学院北京协和医学院
肿瘤医院
NCCN代表:
Robert J. Morgan, Jr., MD
City of Hope Comprehensive
Cancer Center
NCCN卵巢癌临床实践指南(中国版)专家组
组 长:
沈 铿
中国医学科学院北京协和医学院北京协和医院
成 员(按拼音排序):
曹泽毅
清华大学第二附属医院
崔 恒
北京大学人民医院
狄 文
上海交通大学医学院附属仁济医院
丰有吉
复旦大学附属妇产科医院
高雨农
北京大学临床肿瘤学院、北京肿瘤医院
郭丽娜
中国医学科学院北京协和医学院北京协和医院
郝 权
天津医科大学附属肿瘤医院
孔北华
山东大学齐鲁医院
郎景和
中国医学科学院北京协和医学院北京协和医院
李 力
广西医科大学附属肿瘤医院
李子庭
复旦大学附属肿瘤医院
林仲秋
中山大学附属第二医院
执笔人:
刘继红
中山大学附属肿瘤医院
刘丽影
中国医学科学院北京协和医学院肿瘤医院
马 丁
华中科技大学同济医学院附属同济医院
盛修贵
山东省肿瘤医院
宋 磊
中国人民解放军总医院(三○一医院)
魏丽惠
北京大学人民医院
吴令英
中国医学科学院北京协和医学院肿瘤医院
吴 鸣
中国医学科学院北京协和医学院北京协和医院
吴 强
江苏省肿瘤医院
吴小华
复旦大学附属肿瘤医院
向 阳
中国医学科学院北京协和医学院北京协和医院
谢 幸
浙江大学医学院附属妇产科医院
张福泉
中国医学科学院北京协和医学院北京协和医院
NCCN ® 肿瘤学临床实践指南(中国版)2010年 第一版
© National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.
The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive
Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org.
卵巢癌
目录
NCCN卵巢癌专家组成员
NCCN特别鸣谢
指南更新概要
上皮性卵巢癌/输卵管癌/原发性腹膜癌:
● 临床表现、检查、初始治疗(OV-1)
● 经既往手术确诊:手术结果和初始治疗(OV-2)
● 病理分期、初始化疗/初始辅助治疗(OV-3)
● 初始治疗后的治疗:第二次辅助治疗(OV-4)
● 监测/随访、复发肿瘤(OV-5)
● 持续或复发肿瘤的治疗(OV-6)
交界性上皮性卵巢肿瘤(低度恶性潜能):
● 临床表现、初始治疗(OV-7)
● 监测/随访、复发肿瘤(OV-8)
初次手术原则(卵巢癌、输卵管癌、原发性腹膜癌)(OV-A)
化疗原则(卵巢癌、输卵管癌、原发性腹膜癌)(OV-B)
药物反应的处理(OV-C)
辅助的姑息性手术治疗(OV-D)
可以接受的复发治疗方案(OV-E)
卵巢肿瘤少见的病理组织学类型:
● 临床表现、检查、诊断(LCOH-1)
● 生殖细胞肿瘤(LCOH-2)
● 性索-间质肿瘤(LCOH-4)
● 癌肉瘤(恶性混合性苗勒氏瘤)(LCOH-5)
● 可以接受的复发治疗方案(LCOH-A)
分期
讨论
参考文献
作为共识,NCCN肿瘤学临床实践指南反映了作者们对目前认可的治疗方法的观点,欲参考或应用这些指南的临床医师应根据具体的临床情况做出独立的医疗判断,以决定患者所需的护理和治疗。任何寻
求使用这些指南的病人或非医生人员应咨询医生关于它们的合理应用。
NCCN肿瘤学临床实践指南编译力求精确表达反映原版英文指南。NCCN不保证指南编译的有效性,也不承认任何无限制性的担保、表达及暗示。NCCN不担保指南编译或指南本身的精确性和完整性。
NCCN不保证或担保或陈述指南的应用及应用结果。NCCN及其成员不对涉及指南无限制性应用的任何偶然的、间接的、特殊的、惩罚性或作为结果的补偿费承担任何责任。
临床试验:NCCN认为任何肿瘤患者都可以在临床试验中得到最
佳处理,因此特别鼓励肿瘤患者参加临床试验。
NCCN对证据和共识的分类:
除非特别指出,NCCN对所有建议均达成2A类共识。
见NCCN对证据和共识的分类
声明:
本指南中标注“※”处为中国专家根据国内实际情况进行明显改动
或补充之处,内容有别于英文版,参考时请注意。
...